Application 200630

Type: ANDA
Sponsor: MYLAN

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	TADALAFIL	TADALAFIL	TABLET;ORAL	20MG	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A200630-001	TADALAFIL	TADALAFIL	20MG	TABLET / ORAL			2018-08-03

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A200630-001	TADALAFIL	20MG	TABLET / ORAL	AB2	2018-08-03	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A200630-001	TADALAFIL	20MG	TABLET / ORAL	AB2	2018-08-03	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A200630-001	TADALAFIL	20MG	TABLET / ORAL	AB2	2018-08-03	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A200630-001	TADALAFIL	20MG	TABLET / ORAL	AB2	2018-08-03	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A200630-001	TADALAFIL	20MG	TABLET / ORAL	AB2	2018-08-03	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A200630-001	TADALAFIL	20MG	TABLET / ORAL	AB2	2018-08-03	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A200630-001	TADALAFIL	20MG	TABLET / ORAL	AB2	2018-08-03	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A200630-001	TADALAFIL	20MG	TABLET / ORAL	AB2	2018-08-03	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A200630-001	TADALAFIL	20MG	TABLET / ORAL		2018-08-03	`f41ea6bd6efb…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A200630-001	AB2	1	`74a2ff9319b5…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A200630-001	AB2	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A200630-001	AB2	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A200630-001	AB2	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A200630-001	AB2	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A200630-001	AB2	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A200630-001	AB2	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A200630-001	AB2	1	`ea99ee380514…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A200630-001	PC	2019-02-05	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	A200630-001	PC	2019-02-05	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A200630-001	PC	2019-02-05	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A200630-001	PC	2019-02-05	`ea99ee380514…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 7 of 8 · 144 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tadalafil	TADALAFIL	Sun Pharmaceutical Industries, Inc.	168a135b-1454-4def-9b03-c9a470bfcb5f	2023-10-10	Warnings, Adverse reactions	Name fallback brand name: Tadalafil generic name: TADALAFIL
Tadalafil	TADALAFIL	Aphena Pharma Solutions - Tennessee, LLC	6213fd38-9580-4253-91d2-14c28a711c20	2023-08-28	Warnings, Adverse reactions	Name fallback brand name: Tadalafil generic name: TADALAFIL
ALYQ	TADALAFIL	Teva Pharmaceuticals, Inc.	2faa7a55-3054-456b-8465-6ea6dc1c0aa9	2023-04-01	Warnings, Adverse reactions	Name fallback generic name: TADALAFIL
Tadalafil	TADALAFIL	Asclemed USA, Inc.	5ea24573-2d16-40d8-a46c-7b5fa8669e69	2023-03-28	Warnings, Adverse reactions	Name fallback brand name: Tadalafil generic name: TADALAFIL
Tadalafil	TADALAFIL	Asclemed USA, Inc.	30ae58ed-5b56-4513-8eb3-eb4f89b78f9d	2023-03-22	Warnings, Adverse reactions	Name fallback brand name: Tadalafil generic name: TADALAFIL
Tadalafil	TADALAFIL	ANI Pharmaceuticals, Inc.	1dace1e7-c617-492f-bb0d-141bf4e673db	2023-03-08	Warnings, Adverse reactions	Name fallback brand name: Tadalafil generic name: TADALAFIL
Tadalafil	TADALAFIL	Proficient Rx LP	aa345972-40b4-415e-acb5-31b808a8d815	2023-03-01	Warnings, Adverse reactions	Name fallback brand name: Tadalafil generic name: TADALAFIL
tadalafil	TADALAFIL	Proficient Rx LP	ac93704f-8e33-43ba-8b56-3d61092ff1d9	2023-01-01	Warnings, Adverse reactions	Name fallback brand name: tadalafil generic name: TADALAFIL
tadalafil	TADALAFIL	Burel Pharmaceuticals, LLC	a2e7f393-5cfc-45e5-b87d-9e8abc8e4355	2022-12-01	Warnings, Adverse reactions	Name fallback brand name: tadalafil generic name: TADALAFIL
Tadalafil	TADALAFIL	Proficient Rx LP	7a105ef9-7129-4ce1-bd8d-ae316bf348e2	2022-11-01	Warnings, Adverse reactions	Name fallback brand name: Tadalafil generic name: TADALAFIL
TADLIQ	TADALAFIL	CMP Pharma, Inc.	7a909b25-3772-403e-a5fe-e4a040293fb7	2022-10-15	Warnings, Adverse reactions	Name fallback generic name: TADALAFIL
Tadalafil	TADALAFIL	Macleods Pharmaceuticals Limited	93dd604f-8f38-4600-afe8-0fcc92fd2497	2022-09-27	Warnings, Adverse reactions	Name fallback brand name: Tadalafil generic name: TADALAFIL
Tadalafil	TADALAFIL	Proficient Rx LP	b539e862-d5d4-4989-a3dd-1eba66285d53	2022-05-01	Warnings, Adverse reactions	Name fallback brand name: Tadalafil generic name: TADALAFIL
Tadalafil	TADALAFIL	Proficient Rx LP	31c05a53-7282-46d0-81bd-108defe6fb38	2022-04-01	Warnings, Adverse reactions	Name fallback brand name: Tadalafil generic name: TADALAFIL
Tadalafil	TADALAFIL	Proficient Rx LP	6fa9d4fa-86c9-4791-b28b-78e8b9341cea	2022-04-01	Warnings, Adverse reactions	Name fallback brand name: Tadalafil generic name: TADALAFIL
Tadalafil	TADALAFIL	Asclemed USA, Inc.	aba646fe-70c2-1abb-e053-2995a90aa16d	2022-01-28	Warnings, Adverse reactions	Name fallback brand name: Tadalafil generic name: TADALAFIL
Tadalafil	TADALAFIL	Qilu Pharmaceutical Co., Ltd.	f295f164-78fb-4224-b319-9f20b7a453b5	2021-11-17	Warnings, Adverse reactions	Name fallback brand name: Tadalafil generic name: TADALAFIL
tadalafil	TADALAFIL	VKT Pharma Private Limited	b4d9851c-5c06-4532-bd82-16d92b60c28f	2021-11-17	Warnings, Adverse reactions	Name fallback brand name: tadalafil generic name: TADALAFIL
Tadalafil	TADALAFIL	Cipla USA Inc.	cf6fc925-ad20-4ed0-9356-15d24afa8d0b	2020-10-21	Warnings, Adverse reactions	Name fallback brand name: Tadalafil generic name: TADALAFIL
Tadalafil	TADALAFIL	Aphena Pharma Solutions - Tennessee, LLC	36350106-98bc-41fc-bede-8be5e6f54a8a	2020-10-02	Warnings, Adverse reactions	Name fallback brand name: Tadalafil generic name: TADALAFIL

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 4 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
0378-6976	Tadalafil	tadalafil	Mylan Pharmaceuticals Inc.	ANDA	Current
0378-6976	Tadalafil	tadalafil	Mylan Pharmaceuticals Inc.	ANDA	Current
0378-6976	Tadalafil	tadalafil	Mylan Pharmaceuticals Inc.	ANDA	Current
0378-6976	Tadalafil	tadalafil	Mylan Pharmaceuticals Inc.	ANDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
55623	ORIG	2018-09-27